228 related articles for article (PubMed ID: 26094625)
1. Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells.
Ding X; Zhou X; Jiang B; Zhao Q; Zhou G
Mol Med Rep; 2015 Sep; 12(3):4508-4513. PubMed ID: 26094625
[TBL] [Abstract][Full Text] [Related]
2. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
[TBL] [Abstract][Full Text] [Related]
3. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
4. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
[TBL] [Abstract][Full Text] [Related]
5. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
7. Metformin suppresses hypoxia‑induced migration via the HIF‑1α/VEGF pathway in gallbladder cancer in vitro and in vivo.
Ye J; Chen K; Qi L; Li R; Tang H; Zhou C; Zhai W
Oncol Rep; 2018 Dec; 40(6):3501-3510. PubMed ID: 30272364
[TBL] [Abstract][Full Text] [Related]
8. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
9. Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines.
Liu Y; Cui YF
Asian Pac J Cancer Prev; 2013; 14(9):5243-8. PubMed ID: 24175808
[TBL] [Abstract][Full Text] [Related]
10. Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.
Zhou ZL; Luo ZG; Yu B; Jiang Y; Chen Y; Feng JM; Dai M; Tong LJ; Li Z; Li YC; Ding J; Miao ZH
Mol Cancer; 2010 Oct; 9():268. PubMed ID: 20932347
[TBL] [Abstract][Full Text] [Related]
11. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
Hu H; Zhu S; Tong Y; Huang G; Tan B; Yang L
Anticancer Drugs; 2020 Jun; 31(5):483-491. PubMed ID: 31972592
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1α Pathway.
Zhu G; Zhou L; Liu H; Shan Y; Zhang X
Cell Physiol Biochem; 2018; 48(4):1735-1746. PubMed ID: 30078003
[TBL] [Abstract][Full Text] [Related]
14. Effects of all‑trans retinoic acid on VEGF and HIF‑1α expression in glioma cells under normoxia and hypoxia and its anti‑angiogenic effect in an intracerebral glioma model.
Liang C; Guo S; Yang L
Mol Med Rep; 2014 Nov; 10(5):2713-9. PubMed ID: 25201493
[TBL] [Abstract][Full Text] [Related]
15. Effect of triptolide on malignant peripheral nerve sheath tumours in vitro and in vivo.
Wang W; Lin W; Hong B; Li X; Zhang M; Zhang L; Lv G
J Int Med Res; 2012; 40(6):2284-94. PubMed ID: 23321185
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
17. Suppression of 5-lipoxygenase gene is involved in triptolide-induced apoptosis in pancreatic tumor cell lines.
Zhou GX; Ding XL; Huang JF; Zhang H; Wu SB
Biochim Biophys Acta; 2007 Jul; 1770(7):1021-7. PubMed ID: 17434678
[TBL] [Abstract][Full Text] [Related]
18. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
Dai H; Jiang Y; Luo Y; Bie P; Chen Z
Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
[TBL] [Abstract][Full Text] [Related]
19. Triptolide Suppresses Growth of Breast Cancer by Targeting HMGB1 in Vitro and in Vivo.
Jiang W; Chen M; Xiao C; Yang W; Qin Q; Tan Q; Liang Z; Liao X; Mao A; Wei C
Biol Pharm Bull; 2019 Jun; 42(6):892-899. PubMed ID: 30956264
[TBL] [Abstract][Full Text] [Related]
20. MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer.
Yang A; Qin S; Schulte BA; Ethier SP; Tew KD; Wang GY
Cancer Res; 2017 Dec; 77(23):6641-6650. PubMed ID: 28951456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
